SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-061578
Filing Date
2023-11-09
Accepted
2023-11-09 09:00:21
Documents
49
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q evok-20230930.htm   iXBRL 10-Q 1191781
2 EX-10.1 evok-ex10_1.htm EX-10.1 94174
3 EX-31.1 evok-ex31_1.htm EX-31.1 14798
4 EX-31.2 evok-ex31_2.htm EX-31.2 15128
5 EX-32.1 evok-ex32_1.htm EX-32.1 9971
6 EX-32.2 evok-ex32_2.htm EX-32.2 10763
7 GRAPHIC img21427383_0.jpg GRAPHIC 45126
8 GRAPHIC img215261989_0.jpg GRAPHIC 42223
  Complete submission text file 0000950170-23-061578.txt   4174991

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT evok-20230930_def.xml EX-101.DEF 87516
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT evok-20230930.xsd EX-101.SCH 30533
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT evok-20230930_pre.xml EX-101.PRE 170439
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT evok-20230930_lab.xml EX-101.LAB 246558
13 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT evok-20230930_cal.xml EX-101.CAL 22306
43 EXTRACTED XBRL INSTANCE DOCUMENT evok-20230930_htm.xml XML 492638
Mailing Address 420 STEVENS AVENUE SUITE 370 SOLANA BEACH CA 92075
Business Address 420 STEVENS AVENUE SUITE 370 SOLANA BEACH CA 92075 858-345-1494
Evoke Pharma Inc (Filer) CIK: 0001403708 (see all company filings)

IRS No.: 208447886 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36075 | Film No.: 231390277
SIC: 2834 Pharmaceutical Preparations